CS logo
small CS logo
Changhua Christian Hospital; Hematology-Oncology

Changhua, Taiwan

About Changhua Christian Hospital; Hematology-Oncology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Changhua Christian Hospital; Hematology-Oncology


During the past decade, Changhua Christian Hospital; Hematology-Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Changhua Christian Hospital; Hematology-Oncology" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Changhua Christian Hospital; Hematology-Oncology


According to Clinical.Site data, the most researched conditions in "Changhua Christian Hospital; Hematology-Oncology" are "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Changhua Christian Hospital; Hematology-Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Changhua Christian Hospital; Hematology-Oncology


Most popular intervention types in "Changhua Christian Hospital; Hematology-Oncology" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Changhua Christian Hospital; Hematology-Oncology


The vast majority of trials in "Changhua Christian Hospital; Hematology-Oncology" are 3 trials for "All" genders.

Clinical Trials Status at Changhua Christian Hospital; Hematology-Oncology


Currently, there are NaN active trials in "Changhua Christian Hospital; Hematology-Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Changhua Christian Hospital; Hematology-Oncology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Changhua Christian Hospital; Hematology-Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".